WEX Pharmaceuticals Company Profile: Acquisition & Investors

Description

Manufacturer of pharmaceutical products. The company develops and distributes drug and pharmaceutical products to treat local and systemic pain.

Contact Information

Ownership Status

Acquired/Merged
(Operating Subsidiary)

Financing Status

Corporate Backed or Acquired

Primary Industry

Drug Delivery

Other Industries

Pharmaceuticals

Parent Company

Primary Office

+1 (604) 000-0000

What you see here scratches the surface

We’ll help you find what you need

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore WEX Pharmaceuticals‘s full profile, request access.

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)	Citations
EP-1882692-A1	Dimethano-[1,3]dioxocino[6,5-d]pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain	Inactive	28-Jul-2006	0000000000
EP-1844783-A1	Use of 4,9-anhydro-tetrodotoxin for the treatment of diseases related to the voltage-gated sodium channel - subunit nav1.6	Inactive	27-Mar-2006	0000000000	0
EP-1844782-A1	Use of 4,9-anhydro-tetrodotoxin for the treatment of diseases related to the voltage-gated sodium channel subunit nav1.6	Inactive	27-Mar-2006	0000000000	0
EP-1844781-A1	Use of sodium channel blockers for the treatment of preterm labor	Inactive	22-Feb-2006	0000000000	00
CA-2619668-A1	Use of sodium channel blockers for the management of musculoskeletal pain	Inactive	25-Aug-2005	A61K31/519